Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mary-Krause

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Pathologie-Biologie|August 19, 2000
[Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency]M Mary-Krause, C Rabaud, M Jouan, et al.
HIV Medicine|March 28, 2008
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapyS Grabar, E Lanoy, C Allavena, et al.
The Journal of Infectious Diseases|October 29, 2002
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virusP del Giudice, M Mary-Krause, C Pradier, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 1998
AIDS-related primary pulmonary lymphomaP Ray, M Antoine, M Mary-Krause, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pathologie-Biologie|August 19, 2000
[Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency]M Mary-Krause, C Rabaud, M Jouan, et al.
HIV Medicine|March 28, 2008
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapyS Grabar, E Lanoy, C Allavena, et al.
The Journal of Infectious Diseases|October 29, 2002
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virusP del Giudice, M Mary-Krause, C Pradier, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 1998
AIDS-related primary pulmonary lymphomaP Ray, M Antoine, M Mary-Krause, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Pageof 2